Document:

Exhibit
A

 

Form
of 

 

SECURITIES
PURCHASE AGREEMENT

 

This
Securities Purchase Agreement (this “Agreement”) is dated as of October [  ], 2014, (the “Agreement
Date”) between eWellness Healthcare Corporation, a Nevada corporation (the “Company”) with an address
of 11825 Major Street, Culver City, California, and each purchaser identified on Schedule I, as the same may be updated
from time to time in accordance with this Agreement (which purchaser, including its successors and assigns, a “Purchaser”
and collectively, the “Purchasers”).

 

WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(2) of the Securities Act of 1933, as
amended (the “Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell
to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company
as more fully described in this Agreement.

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

 

ARTICLE
I.

DEFINITIONS

 

1.1          Definitions.
In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have
the meanings given to such terms in the Notes (as defined herein), and (b) the following terms have the meanings set forth in
this Section 1.1:

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Agent”
shall have the meaning ascribed to such term in Section 5.2.

 

“Board
of Directors” means the board of directors of the Company.

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of California are authorized or required by law or other governmental action
to close.

 

“Closing”
means the individual and collective reference to the Initial Closing and each subsequent closing on or before the Final Closing
Date with one or more Purchasers of the purchase and sale of the Securities pursuant to Section 2.1

 

“Closing
Date” means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all conditions precedent to (i) each Purchaser’s obligations to pay the Subscription Amount and (ii)
the Company’s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later
than the third Trading Day following the date hereof.

 

“Commission”
means the United States Securities and Exchange Commission.

 

    	 

    	 

    

 

“Common
Stock” means the collective reference to the common stock, par value $0.001 per share of the Company, any shares of
common stock of a successor-in-interest to the Company, and any other class of securities into which such securities may hereafter
be reclassified or changed.

 

“Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
Common Stock.

 

“Company
Counsel” means Hunter Taubman Weiss LLP, with offices located at 130 West 42nd Street, 10th floor, New York, New York
10036.

 

“Converted
Offering” means the Company’s private sale of 1,000,000 shares of Common Stock to investors for total subscription
proceeds of $100,000 that was done pursuant to Rule 506 of Regulation D promulgated under the Securities Act, which was originally
sold. pursuant to the registration statement that was declared effective by the SEC on September 14, 2012.

 

“Converted
Offering Shares” means the 1,000,000 shares of Common Stock issued pursuant to the Converted Offering.

 

“eWellness”
refers to eWellness Corporation, a privately held Nevada corporation.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Final
Closing Date” shall mean that date which shall be the earlier of (a) completion of the sale of all Notes or (b) 5:00
p.m. (EDT) on June 16, 2014, unless extended as per the terms and conditions stated herein.

 

“GAAP”
shall have the meaning ascribed to such term in Section 3.1(g).

 

“Holder”
shall mean the individual or collective reference to each Purchaser or any subsequent holder (whether by purchase, assignment
or other transfer) of the Securities, or any of them.

 

“Indebtedness”
shall mean (a) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred
in the ordinary course of business), (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness
of others, whether or not the same are or should be reflected in the Company’s consolidated balance sheet (or the notes
thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the
ordinary course of business; and (c) the present value of any lease payments in excess of $50,000 due under leases required to
be capitalized in accordance with GAAP.

 

“Initial
Closing” shall mean the Closing of the sale of Notes on the Initial Closing Date.

 

“Initial
Closing Date” shall mean a date which shall be the earlier to occur of (a) completion of the Minimum Offering and receipt
by the Company of the Minimum Offering Amount, or (b) June 16, 2014, which latter date may be extended for up to an additional
60 days by mutual agreement of the Company and the Investors.

 

    	 

    	 

    

 

“Intellectual
Property Rights” shall have the meaning ascribed to such term in Section 3.1(n).

 

“Investor
Information” means all of the information each of the Purchasers provide on the accredited investor certification and
investor profile included after the Signature Page to this Agreement.

 

“Legend
Removal Date” shall have the meaning ascribed to such term in Section 4.2(c).

 

“Liens”
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

“Material
Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

 

“Material
Permits” shall have the meaning ascribed to such term in Section 3.1(l).

 

“Maximum
Offering Amount” shall have the meaning ascribed to such term in Section 2.1(a).

 

“Memorandum”
means the Company’s Confidential Private Placement Memorandum, dated May 19, 2014, as may be amended and/or supplemented,
from time to time, setting forth the terms of the Offering.

 

“Minimum
Offering Amount” shall have the meaning ascribed to such term in Section 2.1(b).

 

“Minimum
Subscription” shall have the meaning ascribed to such term in Section 2.1(a).

 

“Notes”
means the Convertible Promissory Notes being purchased pursuant hereto; which notes mature one (1) year from the effective date
of the Registration Statement (the “Maturity Date”) and are in the form of Exhibit A annexed
hereto and made a part hereof.

 

“Note
Conversion Price” shall have the meaning ascribed to such term in the Notes.

 

“Note
Shares” means the shares of Common Stock issuable upon conversion of the Notes, including the Notes to be issued upon
conversion of the Promissory Notes.

 

“Offering”
shall mean the offering under Rule 506 of the Notes contemplated by this Agreement.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Prior
Securities” means the Converted Offering Shares and Promissory Notes.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.

 

    	 

    	 

    

 

“Promissory
Notes” refer to the Company’s outstanding 12% promissory notes issued on or about April 30, 2014 in the aggregate
principal amount of $130,000, all of which is convertible into the Notes and Warrants on the same terms and in the same amounts
as set forth herein.

 

“PubCo
Investors” means the investors of the Converted Offering.

 

“Registration
Rights Agreement” means the registration rights agreement, dated the date hereof, executed by the Company in favor of
the Purchasers, in the form of Exhibit C attached hereto.

 

“Registrable
Securities” means collectively, the Note Shares, Warrant Shares, Converted Offering Shares and the shares of Common
Stock issuable upon conversion of the Promissory Notes.

 

“Registration
Statement” means the registration statement on Form S-1 the Company shall file to register for resale the Note Shares
and Warrant Shares.

 

“Required
Approvals” shall have the meaning ascribed to such term in Section 3.1(d).

 

“Required
Minimum” means 100% of the Note Shares issuable upon conversion in full of all of the then outstanding Notes, ignoring
any exercise limits set forth therein.

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Rule
424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.

 

“Securities”
means the collective reference to (a) the Notes, (b) the Note Shares (c) the Warrants and (d) the Warrant Shares.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Security
& Pledge Agreement” means that certain Security & Pledge Agreement dated on even date herewith between the Company
and the Investors and is in the form of Exhibit D annexed hereto and made a part hereof.

 

“Short
Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall
not be deemed to include the location and/or reservation of borrowable shares of Common Stock).

 

“Subscription
Amount” means, as to each Purchaser, the aggregate amount to be paid for the Notes purchased hereunder as specified
below such Purchaser’s name on the signature page of this Agreement and next to the heading “Subscription Amount,”
in United States dollars and in immediately available or good funds.

 

    	 

    	 

    

 

“Trading
Day” means a day on which the principal Trading Market is open for trading.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE AMEX, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the
New York Stock Exchange, the OTC Bulletin Board or the OTC Markets Group Inc. (or any successors to any of the foregoing).

 

“Transaction
Documents” means this Agreement, the Security and Pledge Agreement, the Notes, the Investor Information, the Warrants,
the Registration Rights Agreement, all exhibits thereto and hereto and any other documents or agreements executed in connection
with the transactions contemplated hereunder.

 

“Warrants”
means the common stock purchase warrants being issued pursuant to this Offering and are in the form of Exhibit B
annexed hereto and made a part hereof.

 

“Warrant
Shares” means the shares of Common Stock issuable upon exercise of the Warrants, including the Warrants to be issued
upon conversion of the Promissory Notes.

 

ARTICLE
II.

PURCHASE
AND SALE

 

2.1          The
Notes; Subscription Amount, Offering Period

 

a.
       On the Closing Date, upon the terms and subject to the conditions set forth herein,
substantially concurrent with the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell,
and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of up to one million two hundred thousand
($1,200,000) of the Notes (the “Maximum Offering Amount”), pursuant to which the Company shall issue Warrants
to purchase up to an aggregate of 2,400,000 shares of Common Stock at an exercise price of $0.35 per share(the “Exercise
Price”).

 

The
purchase price of each Note shall be equal to the principal amount of such Note (the “Note Purchase Price”).

 

The
Minimum Subscription that can be paid by any Purchaser is Twenty Five Thousand ($25,000) Dollars (the “Minimum Subscription”);
provided that a Subscription Amount of less than $25,000 may be accepted at the sole discretion of the Company.

 

b.
       Notwithstanding the provisions of Section 2.1(a) above, no Closing shall take place
if the aggregate Subscription Amount for the purchase of the Notes hereunder that is received from Purchasers by the expiration
of the Final Closing Date is less than fifty thousand dollars ($50,000) (the “Minimum Offering Amount”). Such
Minimum Offering Amount is required to be purchased for cash by Purchasers and issued by the Company on or before the expiration
of the Final Closing Date. Pending completion of the sale of the Minimum Offering Amount on or before the Final Closing Date,
all funds received from Purchasers shall be held into an ordinary bank account of the Company.

 

If
the Minimum Offering Amount is received by the Initial Closing Date, all fund previously received, net of commissions, if any,
to the Agent and other offering expenses, will be remitted to the Company. If the Minimum Offering Amount is not received by the
Final Closing Date, the Offering will terminate and all received proceeds will be returned to subscribers without interest or
deduction.

 

Following
the Initial Closing, the Company may hold subsequent Closings up to and including the Final Closing Date for all or any portion
of the remaining amount of the Offering not sold at the time of the Initial Closing or any subsequent Closing, provided, however,
that such subsequent Closings must occur no later than the Final Closing Date.

 

    	 

    	 

    

 

c.
       Pending the Initial Closing on the Initial Closing Date and at each subsequent Closing
until the Final Closing Date, each Purchaser shall deliver to the Company, via wire transfer or a certified check, immediately
available funds equal to such Purchaser’s Subscription Amount as set forth on the signature page hereto executed by such
Purchaser. The Company shall deliver to each Purchaser his or its respective the Notes and Warrants, as determined pursuant to
Section 2.2(a) and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing.
Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of
Company Counsel or such other location as the parties shall mutually agree.

 

d.
       The Company shall instruct the Purchaser to deliver to the Company checks made payable
to the order of “eWellness Healthcare Corporation,” or wire transfer to:

 

eWellness
Healthcare Corporation

Bank:
J.P. Morgan Bank

Bank
Address: 8813 S. Sepulveda Blvd.

Los
Angeles, California 90045

Account
Number: 591303800

Routing
Number: 322271627

 

All
such checks and wire transfers remitted to the Company shall be accompanied by information identifying each Purchaser, subscription,
the Purchaser’s social security or taxpayer identification number and address. The checks or wire transfers shall be placed
into an ordinary bank account of the Company and not an escrow account and may become commingled with other funds of the Company
and that the Company has the unconditional right to apply the proceeds thereof in any way.

 

e.
       Subject to receipt of the Minimum Offering, at the Initial Closing, the Company is hereby
expressly and irrevocably authorized by each Purchaser executing this Agreement and delivering his, its or their respective Subscription
Amounts to the Company, to remit (i) amounts representing the Agent’s commissions, if any, directly to the Agent, and (iii)
the balance of such amounts to the Company or any other Person.

 

f.
       Upon completion of the Minimum Offering on the Initial Closing Date and until the Final
Closing Date, the Purchasers shall continue to wire funds and/or deliver checks payable to the Company. At each subsequent Closing
to be held on or before the Final Closing Date, all additional received subscription proceeds from the sale of Notes in excess
of the Minimum Offering, net of commissions to the Agent and other offering expenses, will be remitted to the Company. The Company
is hereby expressly and irrevocably authorized by each Purchaser executing this Agreement and delivering his, its or their respective
Subscription Amounts to the Company, to remit (i) amounts representing the Agent’s commissions directly to the Agent, and
(ii) the balance of such amounts to the Company or any other Person.

 

    	 

    	 

    

 

2.2           Deliveries.

 

(a)
         On or prior to the applicable Closing Date, the Company shall deliver or cause to be
delivered to each Purchaser the following:

 

(i)
        this Agreement duly executed by the Company;

 

(ii)
       the Registration Rights Agreement duly executed by the Company;

 

(iii)
      Notes representing the Subscription Amount paid by the Purchaser; and,

 

(iv)
      Warrants for the Purchaser to purchase up to that number of shares of Common Stock as
is equal to the number of Note Shares underlying the Purchaser’s Notes.

 

(b)
         On or prior to the applicable Closing Date, each Purchaser shall deliver or cause to
be delivered to the Company the following:

 

(i)
       this Agreement duly executed by such Purchaser, which includes the completed Investor
Information; by executing this Agreement, such Purchaser will be deemed to have executed each of the Transaction Documents
and will be bound by each of their terms even if the Purchaser does not physically sign such other Transaction Documents;
and

 

(ii)
       such Purchaser’s Subscription Amount by wire transfer to the account as specified
in writing by the Company or by check.

 

2.3          Closing
Conditions.

 

(a)
       The obligations of the Company hereunder in connection with each Closing are subject
to the following conditions being met:

 

(i)
       the representations and warranties of each Purchaser contained in Section 4, and the
information set forth in the Investor Information, shall be true on and as of the Closing (unless as of a specific date therein
in which case they shall be accurate as of such date) with the same effect as though such representations and warranties had been
made on and as of the Closing (or such other date);

 

(ii)       all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the applicable Closing Date shall
have been performed; and

 

(iii)       the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.

 

(b)       The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being
met:

 

(i)       the
accuracy in all material respects when made and on the applicable Closing Date of the representations and warranties of the Company
contained herein (unless as of a specific date therein);

 

(ii)       all
obligations, covenants and agreements of the Company required to be performed at or prior to the applicable Closing Date shall
have been performed;

 

    	 

    	 

    

 

(iii)       the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement; and

 

(iv)       there
shall have been no Material Adverse Effect with respect to the Company since the date hereof.

 

ARTICLE
III.

REPRESENTATIONS
AND WARRANTIES

 

3.1          Representations
and Warranties of the Company. Except as set forth in the Memorandum, which shall be deemed a part hereof and shall qualify
any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of the Memorandum,
the Company hereby makes the following representations and warranties to each Purchaser:

 

(a)       Organization
and Qualification. The Company is an entity duly incorporated or otherwise organized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use
its properties and assets and to carry on its business as currently conducted. The Company is not in violation or default of any
of the provisions of its articles of incorporation or bylaws. The Company is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may
be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability
of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition
(financial or otherwise) of the Company, taken as a whole, or (iii) a material adverse effect on the Company’s ability to
perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a
“Material Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting
or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

(b)       Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder
and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the
consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the
part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders
in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction
Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in
accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against
the Company in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii)
as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)
insofar as indemnification and contribution provisions may be limited by applicable law.

 

    	 

    	 

    

 

(c)       No
Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby
and thereby do not and will not: (i) conflict with or violate any provision of the Company’s articles of incorporation,
bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice
or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice,
lapse of time or both) of, any agreement, credit facility, debt or other instrument or other understanding to which the Company
is a party or by which any property or asset of the Company is bound or affected, or (iii) subject to the Required Approvals,
conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction
of any court or governmental authority to which the Company is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company is bound or affected; except in the case of each of clauses (ii) and (iii), such
as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(d)       Filings,
Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice
to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than the
filing of Form D with the Commission and such filings as are required to be made under applicable state securities laws (collectively,
the “Required Approvals”).

 

(e)       Issuance
of the Securities. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents. The Note Shares and Warrant Shares, when issued
in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and non-assessable, free and clear
of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents.

 

(f)       Capitalization.
The capitalization of the Company is included in the Memorandum, which also includes the number of shares of Common Stock owned
beneficially, and of record, by Affiliates of the Company as of the date hereof. Other than the Prior Securities, no Person has
any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities contemplated herein and
the Prior Securities, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any
Person any right to subscribe for or acquire any shares of Common Stock, or contracts, commitments, understandings or arrangements
by which the Company is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. Except as
set forth herein, the issuance and sale of the Securities will not obligate the Company to issue shares of Common Stock or other
securities to any Person (other than the Purchasers) and will not result in a right of any holder of Company securities to adjust
the exercise, conversion, exchange or reset price under any of such securities. Except as may be contemplated in the Memorandum,
all of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and non-assessable,
have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation
of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any
stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders
agreements, voting agreements or other similar agreements with respect to the Company’s capital stock to which the Company
is a party or, to the knowledge of the Company, between or among any of the Company’s stockholders.

 

    	 

    	 

    

 

(g)       Shell
Company Status. The Company does not have any registered securities and therefore has not been subject to Rule 144(i) under
the Securities Act.

 

(h)       Intentionally
left blank.

 

(i)       Litigation.
Except as set forth in the Memorandum, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of the Company, threatened against or affecting the Company or any of it’s properties before or by
any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an “Action”) which (i) adversely affects or challenges the legality, validity or enforceability
of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably
be expected to result in a Material Adverse Effect. Neither the Company nor any director or officer, is or has been the subject
of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary
duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the
Commission involving the Company or any current or former director or officer of the Company.

 

(j)       Labor
Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of
the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s employees
is a member of a union that relates to such employee’s relationship with the Company and the Company is not a party to a
collective bargaining agreement, and the Company believes that its relationships with its employees are good. To the knowledge
of the Company, no executive officer of the Company is, or is now expected to be, in violation of any material term of any employment
contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract
or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer
does not subject the Company to any liability with respect to any of the foregoing matters. The Company is in compliance with
all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions
of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.

 

(k)       Compliance.
The Company: (i) is not in default under or in violation of (and no event has occurred that has not been waived that, with notice
or lapse of time or both, would result in a default by the Company), nor has the Company received notice of a claim that it is
in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to
which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived),
(ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or
has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product
quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result
in a Material Adverse Effect.

 

    	 

    	 

    

 

(l)       Regulatory
Permits. The Company possess all certificates, authorizations and permits issued by the appropriate federal, state, local
or foreign regulatory authorities necessary to conduct their respective businesses, except where the failure to possess such permits
could not reasonably be expected to result in a Material Adverse Effect (“Material Permits”), and the Company
has not received any notice of proceedings relating to the revocation or modification of any Material Permit.

 

(m)       Title
to Assets. The Company has good and marketable title in fee simple to all real property owned by it and good and marketable
title in all personal property owned by it that is material to the business of the Company, in each case free and clear of all
Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use
made and proposed to be made of such property by the Company and (ii) Liens for the payment of federal, state or other taxes,
for which appropriate reserves have been made therefore in accordance with GAAP and, the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under lease by the Company are held by it under valid, subsisting
and enforceable leases with which the Company is in compliance.

 

(n)       Intellectual
Property. The Company has, or has rights to use, all patents, patent applications, trademarks, trademark applications, service
marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
as necessary or required for use in connection with its business and which the failure to so have could have a Material Adverse
Effect (collectively, the “Intellectual Property Rights”). The Company has not received a notice (written or
otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or
terminate or be abandoned, within two (2) years from the date of this Agreement. The Company has not received a written notice
of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person,
except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all
such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company has taken reasonable security measures to protect the secrecy, confidentiality and value of all of
their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect.

 

(o)       Transactions
With Affiliates and Employees. Except as set forth in the Memorandum, none of the officers or directors of the Company and,
to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company
(other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing
for the furnishing of services to or by, providing for rental of real or personal property to or from providing for the borrowing
of money from or lending of money to, or otherwise requiring payments to or from any officer, director or such employee or, to
the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is
an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for: (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii)
other employee benefits, including stock option agreements under any stock option plan of the Company.

 

    	 

    	 

    

 

(p)       Certain
Fees. Except as set forth in Section 5.2 of this Agreement, no brokerage or finder’s fees or commissions are or will
be payable by the Company or any Subsidiaries to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall
have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a
type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.

 

(q)       Private
Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, no registration
under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated
hereby.

 

(r)       Investment
Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will
not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as
amended. The Company shall conduct its business in a manner so that it will not become an “investment company” subject
to registration under the Investment Company Act of 1940, as amended.

 

(s)       Registration
Rights. Other than the PubCo Investors and the holders of the Promissory Notes, no Person has any right to cause the Company
to effect the registration under the Securities Act of any securities of the Company or any Subsidiaries.

 

(t)       Disclosure.
All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company its business and the transactions
contemplated hereby, is true and correct and does not contain any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.
The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the
transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.

 

(u)       Tax
Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result
in a Material Adverse Effect, the Company (i) has made or filed all United States federal, state and local income and all foreign
income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid
all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns,
reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes
for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company know of no basis for any
such claim.

 

(v)       No
General Solicitation. Neither the Company nor any person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers
and certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.

 

    	 

    	 

    

 

(w)       Acknowledgment
Regarding Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each of the Purchasers is acting
solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in
any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchasers’ purchase of the Securities. The Company further represents
to each Purchaser that the Company’s decision to enter into this Agreement and the other Transaction Documents has been
based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.

 

(x)       Prior
Legal Matters. To the best of the Company’s knowledge, none of its officers or directors have been (a) subject to voluntary
or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal
agent or similar officer by a court for his business or property; (b) convicted in a criminal proceeding or named as a subject
of a pending criminal proceeding (excluding traffic violations and other minor offenses); (c) subject to any order, judgment,
or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily
enjoining him from engaging, or otherwise imposing limits or conditions on his engagement in any securities, investment advisory,
banking, insurance, or other type of business or acting as an officer or director of a public company; (d) found by a court of
competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission
to have violated any federal or state securities, commodities or unfair trade practices law, which such judgment or finding has
not been subsequently reversed, suspended, or vacated; (e) been convicted, within ten years before the date of this Agreement,
of any felony or misdemeanor: (i) in connection with the purchase or sale of any security; (ii) involving the making of any false
filing with the Securities and Exchange Commission; or (iii) arising out of the conduct of the business of an underwriter, broker,
dealer, municipal securities dealer, investment adviser or paid solicitor of purchasers of securities; (f) subject to a final
order of a state securities commission (or an agency or officer of a state performing like functions); a state authority that
supervises or examines banks, savings associations, or credit unions; a state insurance commission (or an agency or officer of
a state performing like functions); an appropriate federal banking agency; the U.S. Commodity Futures Trading Commission; or the
National Credit Union Administration that: (i) at the date of this Agreement, bars the person from: (1) Association with an entity
regulated by such commission, authority, agency, or officer; (2) Engaging in the business of securities, insurance or banking;
or (3) Engaging in savings association or credit union activities; or (ii) Constitutes a final order based on a violation of any
law or regulation that prohibits fraudulent, manipulative, or deceptive conduct entered within ten years before such sale; (g)
is subject to an order of the Securities and Exchange Commission entered pursuant to section 15(b) or 15B(c) of the Securities
Exchange Act of 1934 (15 U.S.C. 78o(b) or 78o-4(c)) or section 203(e) or (f) of the Investment Advisers Act of 1940 (15 U.S.C.
80b-3(e) or (f)) that, at the date of this Agreement: (i) Suspends or revokes such person’s registration as a broker, dealer,
municipal securities dealer or investment adviser; (ii) Places limitations on the activities, functions or operations of such
person; or (iii) Bars such person from being associated with any entity or from participating in the offering of any penny stock;
(h) is subject to any order of the Securities and Exchange Commission entered within five years before the date of this Agreement
that, at the time of such sale, orders the person to cease and desist from committing or causing a violation or future violation
of: (i) Any scienter-based anti-fraud provision of the federal securities laws, including without limitation section 17(a)(1)
of the Securities Act of 1933 (15 U.S.C. 77q(a)(1)), section 10(b) of the Securities Exchange Act of 1934 (15 U.S.C. 78j(b)) and
17 CFR 240.10b-5, section 15(c)(1) of the Securities Exchange Act of 1934 (15 U.S.C. 78o(c)(1)) and section 206(1) of the Investment
Advisers Act of 1940 (15 U.S.C. 80b-6(1)), or any other rule or regulation thereunder; or (ii) Section 5 of the Securities Act
of 1933 (15 U.S.C. 77e); (I) is suspended or expelled from membership in, or suspended or barred from association with a member
of, a registered national securities exchange or a registered national or affiliated securities association for any act or omission
to act constituting conduct inconsistent with just and equitable principles of trade; (j) has filed (as a registrant or issuer),
or was or was named as an underwriter in, any registration statement or Regulation A offering statement filed with the Securities
and Exchange Commission that, within five years before such sale, was the subject of a refusal order, stop order, or order suspending
the Regulation A exemption, or is, at the date of this Agreement, the subject of an investigation or proceeding to determine whether
a stop order or suspension order should be issued; or (k) is subject to a United States Postal Service false representation order
entered within five years before such sale, or is, at the date of this Agreement, subject to a temporary restraining order or
preliminary injunction with respect to conduct alleged by the United States Postal Service to constitute a scheme or device for
obtaining money or property through the mail by means of false representations.

 

    	 

    	 

    

 

3.2          Representations
and Warranties of the Purchasers. Each Purchaser, for himself, herself, itself and for no other Purchaser, hereby represents
and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein):

 

(a)       Organization;
Authority. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporated or formed with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and
otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document
to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms
hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with
its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.

 

(b)       Own
Account. Such Purchaser understands that the Securities are “restricted securities” and have not been registered
under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account
and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act
or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities
Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons
to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities
law (this representation and warranty not limiting such Purchaser’s right to sell the Securities pursuant to an effective
registration statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring
the Securities hereunder in the ordinary course of its business.

 

    	 

    	 

    

 

(c)       Restricted
Securities. The Purchaser understands that the Securities have not been, and will not be, registered under the Securities
Act of 1933, as amended (the “Securities Act”), and will be issued and sold only pursuant to a specific exemption
from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment
intent and the accuracy of the Purchaser’s representations as expressed herein. The Purchaser understands that the offering
and sale of the Securities is intended to be exempt from registration under the Securities Act, by virtue of Section 4(2) thereof
and the provisions of Regulation D promulgated thereunder, based, in part, upon the representations, warranties and agreements
of the Purchaser contained in this Agreement. The Purchaser understands that the Securities are “restricted securities”
under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Securities
indefinitely unless they are registered with the Securities and Exchange Commission (the “Commission”)
and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser
acknowledges that the Company has no obligation to register or qualify the Securities for resale. The Purchaser further acknowledges
that if an exemption from registration or qualification is available, it may be conditioned on various requirements including,
but not limited to, the time and manner of sale, the holding period for the Securities, and on requirements relating to the Company
which are outside of the Purchaser’s control, and which the Company is under no obligation and may not be able to satisfy.

 

(d)       Purchaser
Status. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on
which it converts the Notes or exercises the Warrants it will be either: (i) an “accredited investor” as defined in
Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer”
as defined in Rule 144A(a) under the Securities Act. Such Purchaser is not required to be registered as a broker-dealer under
Section 15 of the Exchange Act. The Purchaser has truthfully and accurately completed the Investor Information requested in this
Agreement, which is hereby incorporated by reference, and will submit to the Company such further assurances of such status as
may be reasonably requested by the Company.

 

(e)       Experience
of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk
of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment. Purchaser represents
and warrants that Purchaser has only relied on information set forth in the Memorandum in connection with Purchaser’s investment
in the Securities. Purchaser agrees and acknowledges that the Memorandum amends, supplements, and supersedes any prior information
received regarding the Securities.

 

(f)       Ability
to Bear Risk. The Purchaser understands and agrees that purchase of the Securities is a high risk investment and the Purchaser
is able to afford an investment in a speculative venture having the risks and objectives of the Company, including a risk of total
loss of such investment. The Purchaser must bear the substantial economic risks of the investment in the Securities indefinitely
because none of the Securities may be sold, hypothecated or otherwise disposed of unless subsequently registered under the Securities
Act and applicable state securities laws or an exemption from such registration is available.

 

(g)       Prior
Experience. The Purchaser has significant prior investment experience, including investment in non-listed and non-registered
securities. The Purchaser has a sufficient net worth to sustain a loss of its entire investment in the Company in the event such
a loss should occur. The Purchaser’s overall commitment to investments which are not readily marketable is not excessive
in view of the Purchaser’s net worth and financial circumstances and the purchase of the Securities will not cause such
commitment to become excessive. This investment is a suitable one for the Purchaser.

 

    	 

    	 

    

 

(h)       Approval.
The Purchaser understands that neither the Commission nor any state securities commission has approved or disapproved of the Securities
or passed upon or endorsed the merits of the Offering or confirmed the accuracy or determined the adequacy of this Agreement.

 

(i)       No
other documents. In evaluating the suitability of an investment in the Company, the Purchaser has not relied upon any
representation or other information (oral or written) other than as stated in this Agreement or as contained in documents so furnished
to the Purchaser or its Advisors, if any, by the Company in writing.

 

(j)       General
Solicitation. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented
at any seminar or any other general solicitation or general advertisement.

 

(k)       Information.
Purchaser has been given access to full and complete information regarding the Company and has utilized such access to Purchaser’s
satisfaction for the purpose of obtaining such information regarding the Company as Purchaser has reasonably requested. In particular,
Purchaser: (i) has received and thoroughly read and evaluated the Memorandum, including the exhibits, appendices, and subsequent
amendments or updates thereto, as well as the Notes and Warrants; and (ii) has been given a reasonable opportunity to review such
documents as Purchaser has requested and to ask questions of, and to receive answers from, representatives of the Company concerning
the terms and conditions of the Securities and the business and affairs of the Company and to obtain any additional information
concerning the Company’s business to the extent reasonably available so as to understand more fully the nature of this investment
and to verify the accuracy of the information supplied. The Purchaser is satisfied that it has received adequate information with
respect to all matters which it or its Advisors, if any, consider material to its decision to make this investment.

 

(l)       Residence.
Purchaser is presently a bona fide resident of the state or country represented on the signature page hereof and has no present
intention of becoming a resident of any other state, country, or jurisdiction, and the address and Social Security Number/National
Insurance Number (or other applicable number) or Employer Identification Number/Corporate Tax Reference Number (or other applicable
number) set forth on the signature page hereof are Purchaser’s true and correct residential or business address and Social
Security Number/National Insurance Number (or other applicable number) or Employer Identification Number/Corporate Tax Reference
Number (or other applicable number).

 

(m)       U.S.
Person If Purchaser is a “U.S. Person,” Purchaser: (i) if an individual, is at least 21 years of age; (ii) if
an individual, is a citizen or resident of the United States; (iii) has adequate means of providing for Purchaser’s current
needs and personal contingencies; (iv) has no need for liquidity in Purchaser’s investments; (v) maintains Purchaser’s
principal residence or business at the address shown on the signature page hereof; (vi) warrants that all investments in and commitments
to non-liquid investments are, and after Purchaser’s acquisition of the Securities will be, reasonable in relation to Purchaser’s
net worth and current needs; and (vii) warrants that any financial information that is provided herewith by Purchaser, or is subsequently
submitted by Purchaser at the request of the Company, does or will accurately reflect Purchaser’s financial condition with
respect to which Purchaser does not anticipate any material adverse change.

 

(n)       Exemption.
Purchaser agrees and acknowledges that the Company is relying on exemptions from the registration requirements of the Securities
Act and afforded by applicable state and foreign statutes and regulations.

 

    	 

    	 

    

 

(o)       No
Public Market. The Purchaser understands that no public market now exists for any of the securities issued by the Company,
that the Company has made no assurances that a public market will ever exist for the Securities.

 

The
Company acknowledges and agrees that the representations contained in Section 3.2 shall not modify, amend or affect such Purchaser’s
right to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this
Agreement or the consummation of the transaction contemplated hereby.

 

ARTICLE
IV.

OTHER
AGREEMENTS OF THE PARTIES

 

4.1          Registration
Rights.

 

(a)       Registration
Statement. The Company shall file a registration statement on From S-1 registering for resale the Registrable Securities on
or before December 31, 2014 as per the terms of the Registration Rights Agreement.

 

(b)       Withdrawal.
The Company shall withdraw the Registration Statement on Form S-1 (File No. 333-181440)
that was declared effective by the SEC on September 14, 2012.

 

4.2          Transfer
Restrictions.

 

(a)       The
Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144.

 

(b)       The
Purchasers agree to the imprinting, so long as is required by this Section 4.2, of a legend on any of the Securities in the following
form:

 

[NEITHER]
THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS [CONVERTIBLE] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND
EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT
SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED
BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
THIS SECURITY [AND THE SECURITIES ISSUABLE UPON [CONVERSION] OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR”
AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

    	 

    	 

    

 

(c)       Certificates
evidencing the Note Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.2(b) hereof):
(i) while a registration statement covering the resale of such security is effective under the Securities Act, (ii) following
any sale of such Note Shares or Warrant Shares pursuant to Rule 144, (iii) if such Note Shares or Warrant Shares are eligible
for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information required
under Rule 144 as to such Note Shares or Warrant Shares and without volume or manner-of-sale restrictions or (iv) if such legend
is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued
by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion promptly after the Effective Date
if required to effect the removal of the legend hereunder. If all or any Notes are converted or the Warrants are exercised at
a time when there is an effective registration statement to cover the resale of the Note Shares or Warrant Shares, or if such
Note Shares or Warrant Shares may be sold under Rule 144 and the Company is then in compliance with the current public information
required under Rule 144, or if such Note Shares or Warrant Shares may be sold under Rule 144 without the requirement for the Company
to be in compliance with the current public information required under Rule 144 as to such Note Shares or Warrant Shares and without
volume or manner-of-sale restrictions or if such legend is not otherwise required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Note Shares or Warrant
Shares shall be issued free of all legends. The Company agrees that at such time as such legend is no longer required under this
Section 4.2(c), it will, no later than three Trading Days following the delivery by a Purchaser to the Company of a certificate
representing Note Shares or Warrant Shares issued with a restrictive legend (such third Trading Day, the “Legend Removal
Date”), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from
all restrictive and other legends. The Company may not make any notation on its records or give instructions that enlarge the
restrictions on transfer set forth in this Section 4.

 

(d)       Each
Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities
pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements,
or an exemption therefrom, and that if Securities are sold pursuant to a registration statement, they will be sold in compliance
with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates
representing Securities as set forth in this Section 4.2 is predicated upon the Company’s reliance upon this understanding.

 

4.3          Furnishing
of Information. If after the date hereof the Company becomes subject to the rules and regulations of the Exchange Act and
as long as any Purchaser owns Securities, the Company covenants to timely file (or obtain extensions in respect thereof and file
within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange
Act.

 

4.4          Integration.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined
in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require
the registration under the Securities Act of the sale of the Securities.

 

4.5          Conversion
and Exercise Procedures. The Notes shall automatically convert pursuant to the terms set forth therein. The Company shall
deliver Note Shares and Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction
Documents.

 

    	 

    	 

    

 

4.6          Indemnification
of Purchasers. Subject to the provisions of this Section 4.6, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of
a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles
notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”)
harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all
judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such
Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants
or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against
the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is
not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless
such action is based upon a breach of such Purchaser Party’s representations, warranties or covenants under the Transaction
Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such
Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which constitutes fraud, gross negligence,
willful misconduct or malfeasance). If any action shall be brought against any Purchaser Party in respect of which indemnity may
be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall
have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any
Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment
thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time
to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material
conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will
not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company’s
prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that
a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties,
covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.6 shall be made by periodic payments of the amount thereof during the course of the investigation or
defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any
cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject
to pursuant to law.

 

4.7          Reservation
and Listing of Securities.

 

(a)       Following
the Closing, the Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance pursuant to the
Transaction Documents in such amount as may then be required to fulfill its obligations in full under the Transaction Documents.

 

(b)       If,
on any date following the Closing, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is
less than the Required Minimum on such date, then the Board of Directors shall use commercially reasonable efforts to amend the
Company’s certificate or articles of incorporation to increase the number of authorized but unissued shares of Common Stock
to at least the Required Minimum at such time, as soon as practicable.

 

    	 

    	 

    

 

(c)       The
Company shall, if applicable: (i) in the time and manner required by the principal Trading Market, prepare and file with such
Trading Market an additional shares listing application covering a number of shares of Common Stock at least equal to the Required
Minimum on the date of such application, (ii) take all steps necessary to cause such shares of Common Stock to be approved for
listing or quotation on such Trading Market as soon as possible thereafter, (iii) provide to the Purchasers evidence of such listing
or quotation and (iv) maintain the listing or quotation of such Common Stock on any date at least equal to the Required Minimum
on such date on such Trading Market or another Trading Market.

 

4.8          Form
D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall
reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers
at the Closing under applicable securities or “Blue Sky” laws of the states of the United States, and shall provide
evidence of such actions promptly upon request of any Purchaser.

 

4.9          Independent
Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several
and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
of the obligations of any other Purchaser under any Transaction Document. The decision of each Purchaser to purchase Securities
pursuant to the Transaction Documents has been made by such Purchaser independently of any other Purchaser and independently of
any information, materials, statements or opinions as to the business, affairs, operations, assets, properties, liabilities, results
of operations, condition (financial or otherwise) or prospects of the Company which may have been made or given by any other Purchaser
or by any agent or employee of any other Purchaser, and no Purchaser and none of its agents or employees shall have any liability
to any other Purchaser (or any other Person) relating to or arising from any such information, materials, statements or opinions.
Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto,
shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or
create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the
transactions contemplated by the Transaction Documents. Each Purchaser acknowledges that no other Purchaser has acted as agent
for such Purchaser in connection with making its investment hereunder and that no Purchaser will be acting as agent of such Purchaser
in connection with monitoring its investment in the Securities or enforcing its rights under the Transaction Documents. Each Purchaser
shall be entitled to independently protect and enforce its rights, including without limitation the rights arising out of this
Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an
additional party in any Proceeding for such purpose. It is expressly understood and agreed that each provision contained in this
Agreement is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not
between and among the Purchasers.

 

ARTICLE
V. 

MISCELLANEOUS

 

5.1          Termination.
This Agreement may be terminated by any Purchaser, as to such Purchaser’s obligations hereunder only and without any effect
whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Initial
Closing has not been consummated on or before February 21, 2014; provided, however, that such termination will not
affect the right of any party to sue for any breach by any other party (or parties).

 

    	 

    	 

    

 

5.2          Fees
and Expenses. The Company may compensate selected individuals affiliated with the Company and or broker-dealers (“Agents”)
who are members of the Financial Industry Regulatory Authority (“FINRA”) a cash commission equal to 10% of
the aggregate purchase price of the Notes sold in the Offering (the “Agent Fee”). Except as expressly set forth in
the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and
other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery
and performance of this Agreement. The Company shall pay all stamp taxes and other taxes and duties levied in connection with
the delivery of any Securities to the Purchasers.

 

5.3          Entire
Agreement. The Transaction Documents, together with the exhibits thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents and exhibits.

 

5.4          Notices.
All notices and other communications given or made pursuant to this Agreement will be in writing and will be deemed effectively
given: (i) upon personal delivery to the party to be notified; (ii) when sent by confirmed electronic mail or facsimile, if sent
during normal business hours of the recipient, and if not so confirmed, then on the next business day; (iii) five days after having
been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one day after deposit with a nationally
recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications will be sent
to: (x) the Company at the address set forth in the introductory paragraph of this Agreement, Attention: Chief Executive Officer
or facsimile number 310-301-7748]; and (y) the Purchasers at the addresses set forth on the signature page of this Agreement,
(or at such other addresses as will be specified by notice given in accordance with this Section 5.4).

 

5.5          Amendments;
Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed,
in the case of an amendment, by the Company and the Purchasers holding at least 50.1% of the principal amount of the Notes then
outstanding or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought. No waiver
of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall
any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.

 

5.6          Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.

 

5.7          Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of
each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to
whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect
to the transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchasers.”

 

5.8          No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as
otherwise set forth in Section 4.10.

 

    	 

    	 

    

 

5.9          Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall
be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense
of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in Clark County. Each party hereby irrevocably submits to the exclusive jurisdiction of
the state and federal courts sitting in Clark County for the adjudication of any dispute hereunder or in connection herewith or
with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction
Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not
personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served
in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with
evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any other manner permitted by law.

 

5.10          Survival.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.

 

5.11          Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being
understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of
the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature page were an original thereof.

 

5.12          Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid,
illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain
in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.

 

5.13          Rescission
and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of)
any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, including any cure
periods, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company,
any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; provided,
however, that in the case of a rescission of a conversion of Notes or exercise of Warrants, the applicable Purchaser shall
be required to return any shares of Common Stock subject to any such rescinded conversion notice or exercise notice concurrently
with the return to such Purchaser of the aggregate conversion price paid to the Company for such shares and the restoration of
such Purchaser’s right to acquire such shares pursuant to such Purchaser’s Note or Warrant (including, issuance of
a replacement warrant certificate evidencing such restored right).

 

    	 

    	 

    

 

5.14          Replacement
of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory
to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances
shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement
Securities.

 

5.15          Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of
the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the
Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation
the defense that a remedy at law would be adequate.

 

5.16          Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.

 

5.17          Construction.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting
party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and
every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after
the date of this Agreement.

 

5.18          WAIVER
OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. 

 

5.19          SIGNTUARE
PAGE. It is hereby agreed that the execution by a Purchaser of this Agreement, in the place set forth herein, will constitute
agreement to be bound by the terms and conditions hereof. It is hereby agreed by the parties hereby that the execution by the
Purchaser of this Agreement, in the place set forth herein below, will be deemed and constitute the agreement by the Purchaser
to be bound by all of the terms and conditions hereof, as well as by the Security and Pledge Agreement, the Notes, the Warrants
and all of the other documents constituting the Transaction Documents and will be deemed and constitute the execution by the Purchaser
of all such Transaction Documents without requiring the Purchaser’s separate signature on any of such Transaction Documents.

 

(Signature
Pages Follow)

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

	EWELLNESS HEALTHCARE CORPORATION	 
	 	 	 
	By:	 	 
	Name:	Darwin Fogt,	 
	Title:	Chief Executive
    Officer	 
	 		 
	With
    a copy to (which shall not constitute notice):	 
	Hunter Taubman Weiss

130 W. 42nd Street, Suite 1050

New York,
NY 10036 

	 

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE
PAGE FOR PURCHASER FOLLOWS]

  

    	 

    	 

    

 

EWELLNESS
HEALTHCARE CORPORATION

PURCHASER
SIGNATURE PAGE TO

PURCHASE
AGREEMENT

 

Purchaser
hereby elects to purchase a total of
$                                  of Notes.

 

Date
(NOTE: To be completed by the Purchaser):                                            ,
2014

 

 

If
the Purchaser is an INDIVIDUAL, and if purchased as JOINT TENANTS, as

TENANTS
IN COMMON, or as COMMUNITY PROPERTY:

 

	 	 	 	 	 
	 	Print Name(s)	 	Social
    Security Number(s)	 
	 	 	 	 	 
	 	 	 	 	 
	 	Signature(s)
    of Purchaser(s)	 	Signature	 
	 	 	 	 	 
	 	 	 	 	 
	 	Date	 	Address	 

 

If
the Purchaser is a PARTNERSHIP, CORPORATION, LIMITED LIABILITY COMPANY or TRUST:

  

	 	Name
    of Partnership,		Federal
    Taxpayer	 
	 	Corporation, Limited	 	Identification Number	 
	 	Liability Company or Trust	 	 	 

 

		By:
    	 			
	 	Name:	 	 	State
    of Organization	 
	 	Title:	 	 	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	 	Date	 	 	Address	 

 

AGREED
AND ACCEPTED: 

 

EWELLNESS
HEALTHCARE

 

CORPORATION

 

		By:
    	 			
	 	Name:	 	 	Date	 
	 	Title:	 	 	 	 
	 	 	 	 	 	 

  

    	 

    	 

    

 

EWELLNESS
HEALTHCARE CORPORATION

ACCREDITED
INVESTOR CERTIFICATION

 

For
Individual Investors Only

(All
individual investors must INITIAL where appropriate. Where there are joint investors both parties must INITIAL):

 

	Initial
    _________	I
    certify that I have a “net worth” of at least $1 million either individually or through aggregating my individual
    holdings and those in which I have a joint, community property or other similar shared ownership interest with my spouse.
    For purposes hereof, “net worth” shall be deemed to include all of your assets, liquid or illiquid (excluding
    the value of your principal residence), minus all of your liabilities (excluding the amount of indebtedness secured by your
    principal residence up to its fair market value).
	 	 
	Initial
    _________	I
    certify that I have had an annual gross income for the past two years of at least $200,000 (or $300,000 jointly with my spouse)
    and expect my income (or joint income, as appropriate) to reach the same level in the current year.

 

 For
Non-Individual Investors

(all
Non-Individual Investors must INITIAL where appropriate):

 

	Initial
    _________	The
    undersigned certifies that it is a partnership, corporation, limited liability company or business trust that is 100% owned
    by persons who meet either of the criteria for Individual Investors, above.
	 	 
	Initial
    _________	The
    undersigned certifies that it is a partnership, corporation, limited liability company or business trust that has total assets
    of at least $5,000,000 and was not formed for the purpose of investing in Company.
	 	 
	Initial
    _________	The
    undersigned certifies that it is an employee benefit plan whose investment decision is made by a plan fiduciary (as defined
    in ERISA §3(21)) that is a bank, savings and loan association, insurance company or registered investment adviser.
	 	 
	Initial
    _________	The
    undersigned certifies that it is an employee benefit plan whose total assets exceed $5,000,000 as of the date of the Purchase
    Agreement.
	 	 
	Initial
    _________	The
    undersigned certifies that it is a self-directed employee benefit plan whose investment decisions are made solely by persons
    who meet either of the criteria for Individual Investors, above.
	 	 
	Initial
    _________	The
    undersigned certifies that it is a U.S. bank, U.S. savings and loan association or other similar U.S. institution acting in
    its individual or fiduciary capacity.
	 	 
	Initial
    _________	The
    undersigned certifies that it is a broker-dealer registered pursuant to §15 of the Securities Exchange Act of 1934.
	 	 
	Initial
    _________	The
    undersigned certifies that it is an organization described in §501(c)(3) of the Internal Revenue Code with total assets
    exceeding $5,000,000 and not formed for the specific purpose of investing in Company.
	 	 
	Initial
    _________	The
    undersigned certifies that it is a trust with total assets of at least $5,000,000, not formed for the specific purpose of
    investing in Company, and whose purchase is directed by a person with such knowledge and experience in financial and business
    matters that he is capable of evaluating the merits and risks of the prospective investment.

  

	Initial
    _________	The
    undersigned certifies that it is a plan established and maintained by a state or its political subdivisions, or any agency
    or instrumentality thereof, for the benefit of its employees, and which has total assets in excess of $5,000,000.
	 	 
	Initial
    _________	The
    undersigned certifies that it is an insurance company as defined in §2(a)(13) of the Securities Act of 1933, as amended,
    or a registered investment company.

  

    	 

    	 

    

 

EWELLNESS
HEALTHCARE

 CORPORATION

Investor
Profile

(Must
be completed by Purchaser)

 

Section
A - Personal Investor Information

 

Title in
Which Securities Are to be Held:

 

 

Individual
Executing Profile or Trustee:

 

  

Social
Security Numbers / Federal I.D. Number:

 

 

Date
of Birth:                                                    Marital
Status:                                                   

 

Joint Party
Date of Birth:                                                    

 

Investment
Experience (Years):                                                   

 

Annual
Income:                                                    

 

Liquid Net
Worth:                                                    

 

Net Worth:
                                                    

 

	Investment
    Objectives (circle one or more):	Long
    Term Capital Appreciation, Short Term Trading, Businessman’s Risk, Income, Safety of Principal, Tax Exempt Income or
    other

 

Home
Street Address:

 

 

Home
City, State & Zip Code:

  

 

Home Phone:
                                                  
  Home Fax:                                                    

 

Home
Email:                                                     

 

Employer:

 

  

Employer
Street Address:

 

 

Employer
City, State & Zip Code:

 

 

Bus. Phone:
                                                  Bus.
Fax:                                                  

 

Bus. Email:                                                  

 

Type
of Business:

 

    	 

    	 

    

 

EWELLNESS
HEALTHCARE CORPORATION

Investor
Profile

(Must
be completed by Purchaser)

 

Section
B – Entity Investor Information

 

Title in
Which Securities Are to be Held:        

 

 

Authorized
Individual Executing Profile or Trustee:

 

 

Social
Security Numbers / Federal I.D. Number:

 

 

Investment
Experience (Years):                                                

 

Annual Income:
                                                

 

Net Worth:                                               

 

Was
the Trust formed for the specific purpose of purchasing the Common Stock? [  ] Yes [  ] No

 

Principal
Purpose (Trust)                                                                                                                                                                       

 

Type of
Business:                                                                                                                                                                            

 

	Investment
    Objectives (circle one or more):	Long
    Term Capital Appreciation, Short Term Trading, Businessman’s Risk, Income, Safety of Principal, Tax Exempt Income or
    other

 

Street
Address:

 

 

City,
State & Zip Code:

 

 

Phone:                                                                              Fax:                                                               

 

Email:                                                                 

 

    	 

    	 

    

 

Section
C – Form of Payment – Check or Wire Transfer

 

[  ] Check
payable to “EWELLNESS HEALTHCARE CORPORATION.” included with this Purchaser Signature Page.

  

[  ] Wire
funds to:

 

eWellness
Healthcare Corporation

Bank:
J.P. Morgan Bank

Bank
Address: 8813 S. Sepulveda Blvd.

Los
Angeles, California 90045

Account
Number: 591303800

Routing
Number: 322271627

 

Section
D – Securities Delivery Instructions (check one)

  

[  ] 
Please deliver my securities to the address listed in the above Investor Profile.

 

[  ] Please deliver my securities to the below address:

                                                        

                                                       

                                                       

                                                        

 

    	 

    	 

    

 

SCHEDULE
A

 

SCHEDULE
OF PURCHASERS

 

	Purchaser	 	Purchase
    Price/Amount of NoteConvertible
Note No.: CN-      

 

Form
of 

 

12%
SENIOR PROMISSORY NOTE

 

OF

 

EWELLNESS
HEALTHCARE CORPORATION

 

NEITHER
THE ISSUANCE AND SALE OF THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE,
SOLD, TRANSFERRED OR ASSIGNED (i) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT
FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL,
IN A FORM GENERALLY ACCEPTABLE TO THE COMPANY’S LEGAL COUNSEL, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT
OR (ii) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.

 

 

 

	Principal
    Amount:	$[  ]
	Issue Date:	[  ], 2014
	Maturity Date:	One Year From
    the Effective Date of the 

Registration Statement

 

CONVERTIBLE
PROMISSORY NOTE

 

FOR
VALUE RECEIVED, eWellness Healthcare Corporation, a Nevada corporation (hereinafter called “Borrower” or the
“Company”), hereby promises to pay to [ ] (the “Holder”) or order, without demand,
the aggregate principal amount of [ ] ($[ ]) (the “Principal Amount”), plus all accrued interest,
payable on the first anniversary of the Conversion Event Date, as herein after defined, (the first anniversary date being
herein referred to as the “Maturity Date”), if not previously converted as provided herein prior to the Maturity
Date.

 

This
Note (“Note”) is issued pursuant to the terms of a Securities Purchase Agreement (the “Purchase
Agreement”), by and between the Borrower and, inter alia, the Holder, dated as of the Issue Date, and
shall be governed by the terms set forth herein and in the Purchase Agreement. Unless otherwise separately defined herein, all
capitalized terms used in this Note shall have the same meaning as is set forth in the Purchase Agreement. The following terms
shall apply to this Note:

 

    	 

    	 	 	 

    

 

ARTICLE
I

GENERAL
PROVISIONS

 

1.1
Conversion. Following the date on which the Commission declares the Registration Statement effective (the later event being
referred to herein as the “Conversion Event Date”), and at any time prior to maturity, the Holder may convert this
Note into shares of the Company’s Common Stock at a conversion price equal to $0.35 per share, as such price may be adjusted
for security splits, reverse security splits, security dividends and the like as provided herein (as so adjusted, the “Conversion
Price”). Conversion of this Note pursuant to this Section 1.1 shall constitute satisfaction in full of this Note.

 

1.2
Prepayment. This Note may be prepaid at any time by the Borrower without penalty.

 

1.3
Borrower is Permitted to Issue Other Indebtedness; This Indebtedness is Senior Indebtedness. The Borrower is permitted
in the future to issue and create indebtedness and security interests of any kind, provided however that such additional indebtedness
is ranked junior to the Notes. This Note and all of the Notes issued pursuant to the Purchase Agreement shall rank senior to any
other debt and may not be subordinated to any other debt issued by the Company without the written consent of the Holders owning
at least one-third percent (33.3%) of the then outstanding principal balance of all the Notes issued pursuant to the Purchase
Agreement. Notwithstanding anything to the contrary, the obligations of the Company under this Note rank pari passu in right of
payment with the indebtedness of the Company arising from the promissory notes described in Exhibit A hereto.

 

1.4
Interest. The outstanding Principal Amount shall bear interest at the rate of twelve percent (12%) per annum, payable quarterly.
Interest shall be paid in cash, unless the Registration Statement is effective, in which case, interest shall be paid in shares
of the Company’s Common Stock at the Conversion Price. Interest not paid by the Company shall be added to the Principal
Amount at the end of each payment period and will be considered as the Principal Amount upon the earlier of conversion or redemption,
as applicable.

 

    	2

    	 	 	 

    

 

1.5
Unregistered Stock. The Common Stock which will be issued to the Holder pursuant to the conversion will be newly issued,
unregistered Common Stock of the Borrower.

 

1.6
Adjustment of Conversion Price upon Subdivision or Combination of Common Stock. If the Company at any time on or after
the Issue Date subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding
shares of Common Stock into a greater number of shares, the Conversion Price in effect immediately prior to such subdivision will
be proportionately reduced. If the Company at any time on or after the Issue Date combines (by combination, reverse stock split
or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Conversion Price
in effect immediately prior to such combination will be proportionately increased. Any adjustment pursuant to this Section 1.6
shall become effective immediately after the effective date of such subdivision or combination.

 

ARTICLE
II

CONVERSION

 

2.1
Conversion Notice and Delivery of Shares. To effectuate a conversion of this Note as provided in Section 1.1, the Borrower
will complete and deliver to the Holder a Notice of Conversion, a form of which is annexed hereto as Exhibit B (the “Notice
of Conversion”). Within three (3) business days after delivery of such Notice of Conversion, the Borrower will deliver
the applicable number of shares of Common Stock to the Holder.

 

2.2
Representations and Warranties of Borrower. Borrower represents, warrants and covenants that:

 

 A. Following the Issue Date, it will reserve from its authorized and unissued Common Stock a sufficient number of shares of Common Stock to permit the full conversion of the Notes.

 

B.
Upon issuance, the Common Stock will be duly and validly issued, fully paid and non-assessable.

 

    	3

    	 	 	 

    

 

2.3
Representations and Warranties of the Holder. With respect to the Securities to be acquired by the Holder pursuant to the
conversion provided herein, the Holder represents and warrants that the Securities are being acquired for investment for the Holder’s
own account, the Holder is an “accredited investor” pursuant to Regulation D under the Securities Act of 1933,
as amended (the “Securities Act”), the Holder is an experienced investor and can bear the risk of loss of this investment,
and the Holder understands that the Securities will not be registered under the Securities Act. Additional investor representations
will be substantially similar to those to be set forth in the documents for the proposed offering of the Notes of the Company
and will be included in the Purchase Agreement.

 

2.4
Concerning the Shares.

 

A.
Legend. The Securities to be acquired by the Holder pursuant hereto, may not be sold or transferred unless (A) such shares
are sold pursuant to an effective registration statement under the Securities Act, or (B) the Company or its transfer agent shall
have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary for opinions of
counsel in comparable transactions) to the effect that the shares to be sold or transferred may be sold or transferred pursuant
to an exemption from such registration or (C) such shares are sold or transferred pursuant to Rule 144 under the Securities Act
(or a successor rule) (“Rule 144”) or (D) such shares are sold or transferred outside the United States in
accordance with Rule 904 of Regulation S under the Securities Act, or (E) such shares are transferred to an “affiliate”
(as defined in Rule 144) of the Company who agrees to sell or otherwise transfer the shares only in accordance with this Section
2.4. Except as otherwise provided in this Note (and subject to the removal provisions set forth below), until such time as the
Securities issuable upon conversion of the Holder’s Note have been registered under the Act, otherwise may be sold pursuant
to Rule 144 without any restriction as to the number of securities as of a particular date that can then be immediately sold,
each certificate for shares of the Securities that has not been so included in an effective registration statement or that has
not been sold pursuant to an effective registration statement or an exemption that permits removal of the legend, shall bear a
legend substantially in the following form, as appropriate:

 

    	4

    	 	 	 

    

 

THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S.
SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED
OR OTHERWISE TRANSFERRED ONLY (A) TO THE CORPORATION, (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH RULE 904 OF REGULATION
S UNDER THE U.S. SECURITIES ACT, (C) WITHIN THE UNITED STATES AFTER REGISTRATION OR IN ACCORDANCE WITH THE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS UNDER THE U.S. SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER, IF APPLICABLE, AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS, OR (D) WITHIN THE UNITED STATES IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE
U.S. SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS AND THE HOLDER HAS PRIOR TO SUCH SALE FURNISHED TO THE CORPORATION
AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION.

 

B.
Removal of Legend. The legend set forth above shall be removed and the Company shall issue to the Holder a new certificate
therefor free of any transfer legend if (A) the Company shall have received an opinion of counsel, in form, substance and scope
customary for opinions of counsel in comparable transactions, to the effect that a public sale or transfer of such Securities
may be made without registration under the Act and the shares are so sold or transferred, (B) such Holder provides the Company
with reasonable assurances that the Securities (to the extent such securities are deemed to have been acquired on the same date)
can be sold pursuant to Rule 144 or (C) in the case of the Common Stock issuable upon conversion of the Note, such security is
registered for sale by the Holder under an effective registration statement filed under the Act or otherwise may be sold pursuant
to Rule 144 without any restriction as to the number of securities as of a particular date that can then be immediately sold.
The Company shall cause its counsel to issue a legal opinion promptly after the effective date of any registration statement under
the Act registering the resale of the Common Stock issuable upon conversion of the Note if required to effect the removal of the
legend hereunder.

 

    	5

    	 	 	 

    

 

ARTICLE
III

REDEMPTION

 

In
the event the Common Stock shall be listed on a U.S. stock exchange and trade, as determined by the daily closing price, for twenty
(20) consecutive trading days at or above $1.50 per share (the “Redemption Event”), the Company shall have the right,
but not the obligation, to redeem all or any portion of the outstanding Principal Amount of the Note, at which time the Holder
may elect to convert the Note as set forth in Section 1.1 above. No later than ten (10) Business Days following a Redemption Event,
the Company shall deliver written notice thereof via facsimile to the Holder (a “Redemption Notice”).
At any time during the period beginning after the date of the Redemption Notice and ending five (5) Business Days thereafter,
the Holder may submit a Conversion Notice to the Company requesting to convert all or any portion of this Note (“Redemption
Conversion Notice”), to the Company, which Redemption Conversion Notice shall indicate the portion of the Principal
Amount the Holder is electing to convert. The Company shall redeem the then outstanding Principal Amount of the Note, if any,
on the twentieth (20th) Business Day following the date of the Redemption Notice at the Conversion Price, in cash or in shares
of Common stock, at the Company’s sole discretion. The payment in cash for any redemptions shall be in compliance with Rule
419 of the Securities Act. Notwithstanding the foregoing, the Company may only redeem the Notes in shares of Common Stock if from
the date the Holder receives the Redemption Notice through and until the date such redemption is paid in full, the Equity Conditions
have been satisfied, unless waived in writing by the Holder. For purposes of this Article III, Equity Conditions shall mean during
the period in question, (a) the Company shall have duly honored all conversions and redemptions scheduled to occur or occurring
by virtue of one or more Notices of Conversion of the Holder, if any, (b) the Company shall have paid all other amounts owing
to the Holder in respect of this Note, if any, (c)(i) there is an effective registration statement pursuant to which the Holder
is permitted to utilize the prospectus thereunder to resell all of the shares of Note Shares (and the Company believes, in good
faith, that such effectiveness will continue uninterrupted for the foreseeable future) or (ii) all of the Note Shares (and shares
issuable in lieu of cash payments of interest) may be resold pursuant to Rule 144 without volume or manner-of-sale restrictions
or current public information requirements as determined by the counsel to the Company as set forth in a written opinion letter
to such effect, addressed and acceptable to the Holder, (d) the Common Stock is trading on a Trading Market and all of the Note
Shares are listed or quoted for trading on such Trading Market (and the Company believes, in good faith, that trading of the Common
Stock on a Trading Market will continue uninterrupted for the foreseeable future), (e) there is a sufficient number of authorized
but unissued and otherwise unreserved shares of Common Stock for the issuance of all of the shares then issuable pursuant to the
Note, (f) there is no existing Event of Default and no existing event which, with the passage of time or the giving of notice,
would constitute an Event of Default, (g) there has been no public announcement of a pending or proposed Change of Control Transaction
that has not been consummated, (h) the Holder is not in possession of any information provided by the Company that constitutes,
or may constitute, material non-public information and (i) with respect to payments under this Section and Section 1.4, if any,
the number of shares of Common Stock proposed to be issued in respect of such payments, in each case as attributable to all Note
Holders, is less than 10% of the aggregate number of shares of Common Stock traded on the principal Trading Market during the
20 Trading Days immediately prior to such payment date. To the extent redemptions required by this Section 3 are deemed or determined
by a court of competent jurisdiction to be prepayments of the Note by the Company, such redemptions shall be deemed to be voluntary
prepayments.

 

    	6

    	 	 	 

    

 

ARTICLE
IV

EVENT
OF DEFAULT

 

4.1
Event of Default. The occurrence of any of the following events of default (“Event of Default”) shall,
at the option of the Holder hereof, make all sums of principal then remaining unpaid hereon and all other amounts payable hereunder
immediately due and payable, upon demand, subject to Section 1.1 above:

 

A.
Failure to Pay, Etc. The Borrower shall fail to pay the Principal Amount or other sum due under this Note on the Maturity
Date and thirty (30) days shall have elapsed from the Maturity Date and the payment default shall not have been cured in full.

 

B.
Failure to Deliver Common Stock. Borrower fails to deliver Common Stock to the Holder pursuant to and in the form required
by this Note within twenty (20) Business Days after the applicable conversion date.

 

4.2
Redemption Rights. Upon the occurrence and during the continuation of an Event of Default that has not been remedied within
sixty (60) days, the Holder may require the Company to redeem all or any portion of this Note by delivering written notice thereof
(the “Event of Default Redemption Notice”) to the Company, which Event of Default Redemption Notice shall indicate
the portion of this Note the Holder is electing to redeem. Each portion of this Note subject to redemption by the Company pursuant
to this Section 4.2 shall be redeemed by the Company in cash at a price equal to 150% of the Principal Amount being redeemed (the
“Event of Default Redemption Price”). To the extent redemptions required by this Section 4.2 are deemed
or determined by a court of competent jurisdiction to be prepayments of the Note by the Company, such redemptions shall be deemed
to be voluntary prepayments. Notwithstanding anything to the contrary in this Section 4.2, until the Event of Default Redemption
Price is paid in full, the Principal Amount submitted for redemption under this Section 4.2 may be converted, in whole or in part,
by the Holder into Common Stock pursuant to the terms of this Note. In the event of a partial redemption of this Note pursuant
hereto, the Principal Amount redeemed shall be deducted from the Principal Amount due at maturity. The parties hereto agree that
in the event of the Company’s redemption of any portion of the Note under this Section 4.2, the Holder’s damages would
be uncertain and difficult to estimate because of the parties’ inability to predict future interest rates and the uncertainty
of the availability of a suitable substitute investment opportunity for the Holder. Accordingly, any redemption premium due under
this Section 4.2 is intended by the parties to be, and shall be deemed, a reasonable estimate of the Holder’s actual loss
of its investment opportunity and not as a penalty.

 

    	7

    	 	 	 

    

 

ARTICLE
V

SECURED
NOTE

 

5.1
Secured Note. This Note is a secured obligation of the Borrower as set forth in that certain Security and Pledge Agreement
by and between the Borrower and the Holder, dated as of the Issue Date (the “Security Agreement”), and such security
interest shall be governed by the terms set forth therein.

 

ARTICLE
VI

MISCELLANEOUS

 

6.1
Failure or Indulgence Not Waiver. No failure or delay on the part of Holder hereof in the exercise of any power, right
or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or
privilege preclude other or further exercise thereof or of any other right, power or privilege. All rights and remedies existing
hereunder are cumulative to, and not exclusive of, any rights or remedies otherwise available.

 

6.2
Notices. All notices and other communications given or made pursuant to this Note shall be made in accordance with the
Notice provisions set forth in the Purchase Agreement.

 

6.3
Entire Agreement; Amendment. This Note and the Purchase Agreement constitute the entire agreement of the parties relating
to the subject matter hereof, and supersede all prior or contemporaneous agreements, promises, undertakings, negotiations, discussions
or understandings. This Note shall not be modified or amended except in writing executed by both the Holder and the Borrower.

 

6.4
Assignability. This Note shall be binding upon and insure to the benefit of the parties hereto and their respective successors
and assigns.

 

6.5
Cost of Collection. If default is made in any payment relating to this Note or the delivery of Common Stock upon conversion
hereof, Borrower shall pay the Holder hereof all reasonable costs of collection or of obtaining such Common Stock, whichever is
applicable, including but not limited to, reasonable attorneys fees and expenses and court and other related costs.

 

6.6
Governing Law. This Note shall be governed by and construed solely in accordance with the laws of the State of Nevada (including,
but not limited to, Nevada statutes of limitations), other than choice of law provisions. Any action brought by either party against
the other concerning the transactions contemplated by this Agreement shall be brought only in the civil or state courts of Nevada
or in the federal courts located in the State and county of Clark, Nevada. Both parties agree to submit to the jurisdiction of
such courts. Nothing contained herein shall be deemed or operate to preclude the Holder from taking legal action against the Borrower
in any other jurisdiction to enforce a judgment or other decision in favor of the Holder. In the event that any provision of this
Note is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative
to the extent that it may conflict therewith and shall be deemed modified to conform to such statute or rule of law. Any such
provision, which may prove invalid or unenforceable under any law, shall not affect the validity or unenforceability of any other
provision of this Note.

 

    	8

    	 	 	 

    

 

6.7
Maximum Payments. Nothing contained herein shall be deemed to establish or require the payment of a rate of interest or
other charges in excess of the maximum permitted by applicable law. In the event that the rate of interest required to be paid
or other charges hereunder exceed the maximum permitted by such law, any payments in excess of such maximum shall be deducted
from the amounts owed by the Borrower to the Holder or refunded to the Borrower.

 

6.8
Construction. Each party acknowledges that it has had adequate advice and counsel, and agrees that the rule of construction
that ambiguities are to be resolved against the drafting party shall not be applied in the interpretation of this Note to favor
any party against the other.

 

6.9
Shareholder Status. The Holder shall not have rights as a shareholder of the Borrower with respect to unconverted portions
of this Note. However, the Holder will have the rights of a shareholder of the Borrower with respect to the shares of Common Stock
to be received after delivery by the Holder of a Conversion Notice to the Borrower.

 

6.10
Non-Business Days. Whenever any payment or any action to be made shall be due on a Saturday, Sunday or a public holiday
under the laws of the State of Florida, such payment may be due or action shall be required on the next succeeding business day
and, for such payment, such next succeeding day shall be included in the calculation of the amount of accrued interest payable
on such date.

 

6.11
Lost, Stolen or Mutilated Note. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss,
theft, destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of any indemnification undertaking
by the Holder to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of this Note, the
Company shall execute and deliver to the Holder a new Note representing the outstanding Principal. If the Company is required
to issue a new Note, such new Note (i) shall be of like tenor with this Note, (ii) shall represent, as indicated on the face of
such new Note, the Principal remaining outstanding, (iii) shall have an issuance date, as indicated on the face of such new Note,
which is the same as the Issuance Date of this Note, (iv) shall have the same rights and conditions as this Note, and (v) shall
represent accrued and unpaid Interest, if any, on the Principal of this Note, from the Issuance Date.

 

6.12
CANCELLATION. After all Principal and other amounts at any time owed on this Note have been paid in full or this Note has
been converted in full, this Note shall automatically be deemed canceled, shall be surrendered to the Company for cancellation
and shall not be reissued.

 

[SIGNATURE
PAGE FOLLOWS]

 

    	9

    	 	 	 

    

 

IN
WITNESS WHEREOF, Borrower has caused this Note to be signed in its name by an authorized officer as of the [ ] day
of October, 2014.

 

	 	EWELLNESS
    HEALTHCARE CORPORATION
	 	 
	 	 
	 	Name: Darwin Fogt
	 	Title: Chief Executive
    Officer

 

    	10

    	 	 	 

    

 

Exhibit
A

Outstanding
Indebtedness

 

    	11

    	 	 	 

    

 

Exhibit
B

EWELLNESS
HEALTHCARE CORPORATION

CONVERSION
NOTICE

 

Reference
is made to the Convertible Note (the “Note”) issued to the undersigned by eWellness Healthcare Corporation,
a Nevada corporation (the “Company”). In accordance with and pursuant to the Note, the undersigned hereby elects
to convert all or a portion of the Principal Amount (as defined in the Note) of the Note indicated below into shares of common
stock, par value $0.001 per share, of the Company (the “Common Stock”), as of the date specified below.

 

	Conversion
    Date:	 	 

 

	Aggregate
    Principal Amount to be converted:	 	 

 

	Conversion
    Price:	 	 

 

	Number
    of shares of Common Stock to be issued:	 	 

 

Please
issue the Common Stock into which the Note is being converted in the following name and to the following address:

 

	Issue
    to:	 	 
	 	 	 
	 	 	 

 

	Facsimile
    Number:	 	 

 

	Holder:	 	 

 

	By:	 	 

 

	Title:	 	 

 

	Dated:	 	 

 

	Account
    Number:	 	 

	(if electronic book entry transfer)

 

	Transaction
    Code Number:	 	 

	(if electronic book entry transfer)

 

	Installment Amount(s) to be reduced (and corresponding Installment Date(s)) and amount of reduction:	 

 

    	12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]